Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refractory NHL

Translational research: from bench to bedside

European guidelines for breast cancer treatment

ESMO ranking of the clinical benefits of new drugs

Back to work: employment protections for patients and their families

The recent past and near future of drug approvals in Europe

Aromatase gene amplification

Personalised medicine for rare cancers

Gastrectomy and oral drug prescription

Clinical potential of trastuzumab biosimilar CTP6

Updates in melanoma: Treating BRAF and brain metastases

Bendamustine for indolent lymphoma reduces relapse after 10 years